β2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts
- 1 May 1998
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 53 (5), 1365-1373
- https://doi.org/10.1046/j.1523-1755.1998.00882.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Protein glycation in the kidney: Role in diabetes and agingKidney International, 1996
- B-Myb Expression in Vascular Smooth Muscle Cells Occurs in a Cell Cycle-dependent Fashion and Down-regulates Promoter Activity of Type I Collagen GenesPublished by Elsevier BV ,1996
- Is β2-microglobulin a mediator of bone disease?Kidney International, 1995
- β2-Microglobulin Modified with Advanced Glycation End Products Induces Interleukin-6 from Human Macrophages: Role in the Pathogenesis of Hemodialysis-Associated AmyloidosisBiochemical and Biophysical Research Communications, 1994
- beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.JCI Insight, 1993
- Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.JCI Insight, 1993
- Collagen TypesPublished by Ovid Technologies (Wolters Kluwer Health) ,1992
- Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins.The Journal of Experimental Medicine, 1991
- Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factorsNature, 1986
- Improved technique utilizing nonfat dry milk for analysis of proteins and nucleic acids transferred to nitrocelluloseGene Analysis Techniques, 1984